ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in ESSA Pharma Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +2 vs. Q4 2023
- Shares held
- 35.0M
- +264.7K (+0.8%) vs. Q4 2023
- Total value
- $297.5M
- +$68.0M (+29.6%) vs. Q4 2023
- New holders
- 6
- 5 more added
- Sold out
- 4
- 10 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 32 | $4.30M |
| Q2 2025 | 36 | $52.7M |
| Q1 2025 | 36 | $50.1M |
| Q4 2024 | 45 | $58.8M |
| Q3 2024 | 32 | $212.7M |
| Q2 2024 | 31 | $185.1M |
| Q1 2024 | 33 | $297.5M |
| Q4 2023 | 31 | $229.4M |
| Q3 2023 | 36 | $103.4M |
| Q2 2023 | 39 | $89.8M |
| Q1 2023 | 37 | $98.3M |
| Q4 2022 | 45 | $84.1M |
| Q3 2022 | 54 | $62.2M |
| Q2 2022 | 59 | $119.0M |
| Q1 2022 | 70 | $229.9M |
| Q4 2021 | 60 | $530.1M |
| Q3 2021 | 75 | $297.4M |
| Q2 2021 | 80 | $976.0M |
| Q1 2021 | 70 | $895.7M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding ESSA Pharma Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 8 | $68 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 21 | $178 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 48 | $408 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 50 | $425 | 0.00% | 00.0% | Unchanged |
| Laurel Wealth Advisors LLC | 600 | $5.09K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 900 | $7.29K | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 2,500 | $21.1K | 0.00% | +2,500 | New |
| UBS Group AG | 3,626 | $30.8K | 0.00% | −1,269−25.9% | Reduced |
| Simplex Trading, LLC | 4,329 | $36.0K | 0.00% | +147+3.5% | Added |
| EntryPoint Capital, LLC | 4,420 | $37.5K | 0.03% | +4,420 | New |
| BlackRock Inc. | 5,609 | $47.6K | 0.00% | −2,068−26.9% | Reduced |
| Advisor Group Holdings, Inc. | 6,000 | $50.9K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 14,052 | $119.3K | 0.00% | +14,052 | New |
| Tucker Asset Management LLC | 16,097 | $136.7K | 0.03% | +16,097 | New |
| Geode Capital Management, LLC | 26,858 | $228.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 30,775 | $262.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 36,518 | $310.0K | 0.00% | −227,089−86.1% | Reduced |
| BNP Paribas Arbitrage, SA | 42,495 | $360.8K | 0.00% | −14,971−26.1% | Reduced |
| American Century Companies Inc | 46,176 | $392.0K | 0.00% | +26,132+130.4% | Added |
| D. E. Shaw & Co., Inc. | 65,081 | $552.5K | 0.00% | −134,572−67.4% | Reduced |
| CIBC World Markets Inc. | 80,857 | $686.0K | 0.00% | −30,843−27.6% | Reduced |
| Parkman Healthcare Partners LLC | 251,695 | $2.14M | 0.26% | +251,695 | New |
| Schonfeld Strategic Advisors LLC | 368,500 | $3.13M | 0.02% | +368,500 | New |
| Rock Springs Capital Management LP | 677,005 | $5.75M | 0.15% | 00.0% | Unchanged |
| Rhenman & Partners Asset Management AB | 911,820 | $7.74M | 0.73% | +555,320+155.8% | Added |
| Janus Henderson Group PLC | 1,175,242 | $9.98M | 0.01% | +85,760+7.9% | Added |
| Adage Capital Partners GP, L.L.C. | 1,580,375 | $13.4M | 0.03% | +444,444+39.1% | Added |
| RTW Investments, LP | 2,298,662 | $19.5M | 0.29% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 2,980,420 | $25.3M | 1.26% | −282,080−8.6% | Reduced |
| Soleus Capital Management, L.P. | 3,589,558 | $30.5M | 2.68% | −738,064−17.1% | Reduced |
| Morgan Stanley | 4,178,548 | $35.5M | 0.00% | −8,030−0.2% | Reduced |
| Bellevue Group AG | 7,889,583 | $67.0M | 1.02% | −9,000−0.1% | Reduced |
| BVF Inc | 8,748,629 | $74.3M | 2.04% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −24,234−100.0% | Sold out |
| Privium Fund Management (UK) Ltd | 0 | $0 | 0.00% | −20,032−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −11,175−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −971−100.0% | Sold out |